Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model

The American Journal of Pathology
Jose G TrevinoGary E Gallick

Abstract

The nonreceptor protein tyrosine kinase Src is overexpressed in 70% of pancreatic adenocarcinomas. Here, we describe the effect of molecular and pharmacological down-regulation of Src on incidence, growth, and metastasis of pancreatic tumor cells in an orthotopic model. Src expression in L3.6pl human pancreatic tumor cells was reduced by stable expression of a plasmid encoding small interfering RNA (siRNA) to c-src. In stable siRNA clones, Src expression was reduced >80%, with no change in expression of the related kinases c-Yes and c-Lyn, and proliferation rates were similar in all clones. Phosphorylation of Akt and p44/42 Erk mitogen-activated protein kinase and production of VEGF and IL-8 in culture supernatants were also reduced (P < 0.005). On orthotopic implantation of varying cell numbers into nude mice, tumor incidence was unchanged; however, in the siRNA clones, large tumors failed to develop, and incidence of metastasis was significantly reduced, suggesting that c-Src activity is critical to tumor progression. To examine this possibility further, animals bearing established wild-type tumors were treated with the Src/Abl-selective inhibitor BMS-354825 (dasatinib). Tumor size was decreased, and incidence of metastases w...Continue Reading

References

Jan 1, 1993·The Journal of Clinical Investigation·M S TalamontiG E Gallick
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J RakR S Kerbel
Apr 1, 1998·Journal of the National Cancer Institute·J YonedaI J Fidler
Sep 23, 2000·Cancer Control : Journal of the Moffitt Cancer Center·D Coppola
Apr 12, 2002·Oncogene·Brigitte BoyerMarie-France Poupon
Jul 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nick MaiseyMark Hill
Nov 7, 2002·Oncogene·T Christopher WindhamGary E Gallick
Jul 30, 2003·Cancer Metastasis Reviews·Justin M Summy, Gary E Gallick
Aug 30, 2003·Surgery·Hiromichi ItoEdward E Whang
Oct 23, 2003·Digestive Diseases·J A Palesty, S J Dudrick
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark S DuxburyEdward E Whang
Jun 8, 2004·Current Pharmaceutical Design·A Y Tsygankov, S K Shore
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maksim V YezhelyevChristiane J Bruns

❮ Previous
Next ❯

Citations

Apr 25, 2012·Cell and Tissue Research·Dietmar W SiemannWenyin Shi
Jul 18, 2009·Journal of Molecular Modeling·Ran CaoHuabei Zhang
Apr 23, 2008·Cancer Metastasis Reviews·Alexios StrimpakosKostas N Syrigos
Nov 2, 2012·Cancer Metastasis Reviews·Wanglong Qiu, Gloria H Su
Dec 2, 2011·Clinical & Experimental Metastasis·Lori RiceDietmar W Siemann
Nov 28, 2012·Investigational New Drugs·David S HongRazelle Kurzrock
Oct 16, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Miguel Quintela-FandinoRamon Colomer
Sep 30, 2009·Nature Reviews. Clinical Oncology·Lori C KimEric B Haura
Jun 10, 2009·Nature Reviews. Gastroenterology & Hepatology·Han H Wong, Nicholas R Lemoine
Jan 19, 2011·Oncogene·D J ShieldsD A Cheresh
May 20, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R S Finn
Mar 14, 2007·Anti-cancer Drugs·Ami N Shah, Gary E Gallick
Sep 5, 2006·Cancer Research·Liz Y HanAnil K Sood
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Priya KoppikarJennifer R Grandis
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Divas Neupane, Murray Korc
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersFaye M Johnson
Jan 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei LiangRichard Jove
Jan 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nagathihalli S NagarajNipun B Merchant
Aug 5, 2010·Molecular Cancer Therapeutics·Nagathihalli S NagarajNipun B Merchant
Nov 18, 2008·Molecular Cancer Research : MCR·Ralf BuettnerRichard Jove
Sep 22, 2007·The Journal of Clinical Investigation·Jing ZhangGary E Gallick
Jan 2, 2010·Molecular Cancer·Jiyuan KeSubbarao Bondada
Apr 28, 2011·The Oncologist·Lauren N PulsWells Messersmith
Oct 23, 2014·Therapeutic Delivery·Paul ZarogoulidisKonstantinos Zarogoulidis
Feb 19, 2011·Cancer Research·Shahana MajidRajvir Dahiya
Dec 8, 2006·Expert Opinion on Therapeutic Targets·Jade HomsiAdil Daud

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.